Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis
Main Authors: | Jocelyn M. Choo, Guy C. J. Abell, Rachel Thomson, Lucy Morgan, Grant Waterer, David L. Gordon, Steven L. Taylor, Lex E. X. Leong, Steve L. Wesselingh, Lucy D. Burr, Geraint B. Rogers, Mariana Castanheira |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2018-04-01
|
Series: | mSphere |
Similar Items
-
Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy
by: Steven L. Taylor, et al.
Published: (2018-08-01) -
Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.
by: Alice C-H Chen, et al.
Published: (2015-01-01) -
Phenotyping bronchiectasis based on aetiology, exacerbation characteristics and response to erythromycin
by: Scadding, Alys Jane
Published: (2018) -
The microbiome in bronchiectasis
by: Hollian Richardson, et al.
Published: (2019-09-01) -
Bordetella bronchiseptica in non-cystic fibrosis bronchiectasis
by: Elham Karamooz, et al.
Published: (2018-01-01)